Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 1/2007

01-07-2007 | Progress in Hematology

Nationwide Survey of Hemophagocytic Lymphohistiocytosis in Japan

Authors: Eiichi Ishii, Shouichi Ohga, Shinsaku Imashuku, Masaki Yasukawa, Hiroyuki Tsuda, Ikuo Miura, Ken Yamamoto, Hisanori Horiuchi, Kenzo Takada, Koichi Ohshima, Shigeo Nakamura, Naoko Kinukawa, Kazuo Oshimi, Keisei Kawa

Published in: International Journal of Hematology | Issue 1/2007

Login to get access
Metadata
Title
Nationwide Survey of Hemophagocytic Lymphohistiocytosis in Japan
Authors
Eiichi Ishii
Shouichi Ohga
Shinsaku Imashuku
Masaki Yasukawa
Hiroyuki Tsuda
Ikuo Miura
Ken Yamamoto
Hisanori Horiuchi
Kenzo Takada
Koichi Ohshima
Shigeo Nakamura
Naoko Kinukawa
Kazuo Oshimi
Keisei Kawa
Publication date
01-07-2007
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 1/2007
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.07012

Other articles of this Issue 1/2007

International Journal of Hematology 1/2007 Go to the issue

Progress in Hematology

Mesenchymal Stem Cells in Cancer: Tumor-Associated Fibroblasts and Cell-Based Delivery Vehicles

Case Report

Oral Melphalan, Dexamethasone, and Thalidomide for the Treatment of Refractory Multiple Myeloma

OriginalPaper

Human Leukocyte Antigens A and B Loci Genotyping by Reference Strand-Mediated Conformation Analysis in Hematopoietic Stem Cell Transplantation Donor Selection

Progress in Hematology

Conversion of Cultured Monocytes/Macrophages into Endothelial-Like Cells through Direct Contact with Endothelial Cells

Case Report

Nonsecretory Primary Plasma Cell Leukemia with Good Response to Thalidomide-Based Treatment

Progress in Hematology

Prevalence and Incidence of Anemia in Japanese Cancer Patients Receiving Outpatient Chemotherapy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits